Industry Groups Take Lead In Outing Drug Disguised As Dietary Supplement
This article was originally published in The Rose Sheet
Executive Summary
Four groups say drug identified as “phenibut” is being used in products fraudulently labeled as supplements. The drug, reportedly developed in the former Soviet Union for brain-enhancing properties, has been found in products typically marketed for cognitive benefit and mood enhancement."We're not going to wait for someone to tell us this is not a dietary ingredient," says CRN executive Duffy MacKay.
You may also be interested in...
US Supplement Firm Warned About Phenibut After Failing To Pull PTSD, Detox, Anxiety Claims
Latest FDA warning to Chill6 doesn’t reference previous letter but lists larger number of violations along with more details about the problems. Agency also recently added salt scrub therapies to its list of products as marketed with fraudulent coronavirus treatment claims.
Opioid Treatment Claims Linked To Depression Drug Found In Supplements
FDA warns MA Labs and Jack B Goods about online claims that their tianeptine-containing products treat opioid use disorder, pain and anxiety and other violative and unproven claims. CDC reports a jump in poison control center reports on tianeptine, which is approved outside the US to treat depression.
Health, Beauty And Wellness News: Nestle Compleat, FDA Nutrition Strategy
Supplement OWL sports CDX; FDA schedules Nutrition Strategy meeting, improves food substances inventory; Innotech imports Wholy Tea to US; Thorne adds Bommarito to exclusive provider list; and Nestle Compleat line blended for tube-feeding.